Department of Biochemistry and Molecular Biology, ERI BioTecMed, University of Valencia, 46100 Valencia, Spain.
Viruses. 2019 Mar 7;11(3):229. doi: 10.3390/v11030229.
Fusion of viral and cellular membranes is a key step during the viral life cycle. Enveloped viruses trigger this process by means of specialized viral proteins expressed on their surface, the so-called viral fusion proteins. There are multiple assays to analyze the viral entry including those that focus on the cell-cell fusion induced by some viral proteins. These methods often rely on the identification of multinucleated cells (syncytium) as a result of cell membrane fusions. In this manuscript, we describe a novel methodology for the study of cell-cell fusion. Our approach, named Bimolecular Multicellular Complementation (BiMuC), provides an adjustable platform to qualitatively and quantitatively investigate the formation of a syncytium. Furthermore, we demonstrated that our procedure meets the requirements of a drug discovery approach and performed a proof of concept small molecule high-throughput screening to identify compounds that could block the entry of the emerging Nipah virus.
病毒和细胞膜的融合是病毒生命周期中的一个关键步骤。包膜病毒通过其表面表达的特殊病毒蛋白,即所谓的病毒融合蛋白,触发这个过程。有多种分析病毒进入的方法,包括那些专注于某些病毒蛋白诱导的细胞-细胞融合的方法。这些方法通常依赖于识别多核细胞(合胞体)作为细胞膜融合的结果。在本文中,我们描述了一种研究细胞-细胞融合的新方法。我们的方法,命名为双分子多细胞互补(BiMuC),提供了一个可调节的平台,用于定性和定量研究合胞体的形成。此外,我们证明了我们的程序符合药物发现方法的要求,并进行了小分子高通量筛选的概念验证,以鉴定可以阻止新兴尼帕病毒进入的化合物。